| 000 | 01693 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518033221.0 | ||
| 264 | 0 | _c20200214 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1476-5594 | ||
| 024 | 7 |
_a10.1038/s41388-019-0802-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHounjet, Judith | |
| 245 | 0 | 0 |
_aThe anti-malarial drug chloroquine sensitizes oncogenic NOTCH1 driven human T-ALL to γ-secretase inhibition. _h[electronic resource] |
| 260 |
_bOncogene _c07 2019 |
||
| 300 |
_a5457-5468 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmyloid Precursor Protein Secretases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAntimalarials _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aChloroquine _xpharmacology |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma _xmetabolism |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, Notch1 _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aHabets, Roger | |
| 700 | 1 | _aSchaaf, Marco B | |
| 700 | 1 | _aHendrickx, Tessa C | |
| 700 | 1 | _aBarbeau, Lydie M O | |
| 700 | 1 | _aYahyanejad, Sanaz | |
| 700 | 1 | _aRouschop, Kasper M | |
| 700 | 1 | _aGroot, Arjan J | |
| 700 | 1 | _aVooijs, Marc | |
| 773 | 0 |
_tOncogene _gvol. 38 _gno. 27 _gp. 5457-5468 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41388-019-0802-x _zAvailable from publisher's website |
| 999 |
_c29571828 _d29571828 |
||